#1755 on the rich list of 14,452 insiders
Jason Gardner
See Remarks at Dianthus Therapeutics. Based in Cambridge, Massachusetts.
$79.9M
in disclosed stock, −$265K (−0.33%) today
Market closed. Prices as of Nov 20, 4:05 PM ET
- Rank
- 1755th of 14,452
- Companies held
- 1
- Largest holding
- DNTH, 100.0% of total
- Latest SEC filing
- Nov 30, 2022
What the $79.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Dianthus Therapeutics DNTH Common Stock | Through P.S. Gardner Irrevocable Trust | 359,092 | $84.55 | $30.4M | 38.0% | Form 4, Nov 30, 2022 |
| Dianthus Therapeutics DNTH Common Stock | Through J.P. Gardner Irrevocable Trust | 292,990 | $84.55 | $24.8M | 31.0% | Form 4, Nov 30, 2022 |
| Dianthus Therapeutics DNTH Common Stock | Directly | 292,872 | $84.55 | $24.8M | 31.0% | Form 4, Nov 30, 2022 |
Share counts are the amounts Jason Gardner reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1752 | Edmond J. English Director, Bob's Discount Furniture. Burlington, NJ | $80.1M |
| 1753 | Daniel D. Springer Director, DocuSign. New York, NY | $80.1M |
| 1754 | Emil D. Kakkis President & CEO, Ultragenyx Pharmaceutical. Novato, CA | $80.0M |
| 1755 | Jason Gardner See Remarks, Dianthus Therapeutics. Cambridge, MA | $79.9M |
| 1756 | Christa Davies Chief Financial Officer, Aon. New York, NY | $79.8M |
| 1757 | James G. Shiel EVP - Investments, W. R. Berkley. Greenwich, CT | $79.8M |
| 1758 | Elinor Mertz Chief Financial Officer, Airbnb. San Francisco, CA | $79.7M |
Other Dianthus Therapeutics insiders
All DNTH insiders- Leon O. Moulder Jr.$121MDirector. #1155 overall
- Marino Garcia$5.5MCEO AND PRESIDENT. #13245 overall
Questions
How much stock does Jason Gardner own?
Jason Gardner holds $79,895,861 in listed stock based on SEC filings and current prices, mostly Dianthus Therapeutics (DNTH). That ranks 1755th on the Stock Rich List.
Is this Jason Gardner's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.